Harrow Health Inc
HROW
$27.86-3.11%
Delayed · as of Oct 16, 2026, 2:00 PM ET
Mkt cap
$1.28B
EV/Sales
5.36
P/E ratio
N/A
FY2025 Revenue
$272.30M
EPS (TTM)
$-0.99
Gross Margin (FY2025)
75.05%
Profit Margin (FY2025)
-1.89%
Beta
0.40
Div yield
N/A
Sector
Healthcare
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HROW revenue for 2025-12-31 was $272.3M. Net income was -$5.1M. Revenue was up 36.4% from 2024-12-31 to 2025-12-31. HROW currently screens at market cap $1.28B.
Use this HROW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full HROW income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Harrow Health Inc (HROW) revenue for Dec 31, 2025 was $272.3M. Net income was -$5.1M. Statements: https://lician.com/financials/hrow
Harrow Health Inc (HROW) market capitalization is $1.28B on the latest cached snapshot.
Harrow Health Inc (HROW) cached previous close $28.75; day range $27.86 – $28.59; volume 260,399. Session quote: https://lician.com/quote/hrow
Harrow Health Inc (HROW) latest cached earnings event is "HROW earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached HROW filing is 8-K · Oct 5, 2026. Filings: https://lician.com/sec/hrow